Speakers

Confirmed International Speakers

 

Lucy Raymond.jpg

Professor Lucy Raymond - Professor of Medical Genetics and Neurodevelopment at the University of Cambridge and Honorary Consultant in Medical Genetics at Cambridge University Hospital, Cambridge Biomedical Campus, UK

Lucy Raymond is Professor of Medical Genetics and Neurodevelopment at the University of Cambridge and Honorary Consultant in Medical Genetics at Cambridge University Hospital, Cambridge Biomedical Campus, UK. Her research interest is understanding the genetic basis of intellectual disability and has identified many disease causing genes over the years which have been rapidly translated into clinical service. She leads several collaborative efforts to identify rare disease genes where neurological conditions predominate using whole genome sequence analysis. She is currently Director of the East England Genomics Medicine Centre.

   
Jason-Vassy-120x150.jpg

Assistant Professor Jason Vassy, MD – Department of Medicine, Harvard Medical School; Clinician-Investigator, Brigham and Women’s Hospital, Boston

Jason Vassy, MD is a primary care physician in the VA Boston Healthcare System, Assistant Professor at the Department of Medicine, Harvard Medical School, and Clinician-Investigator at the Brigham and Women’s Hospital, Boston. He is an investigator in the G2P program, undertaking Research in Translational Genomics and Health Outcomes.

Dr Vassy has a Masters of Public Health from The Johns Hopkins University and completed his medical training from the Washington University School of Medicine in St Louis. His key research interests are in patient responses to genetic risk, how primary care physicians deal with genome sequencing results, the downstream implications of incorporating genomics into routine healthcare, and in integrating pharmacogenomics in clinical care

 

 

Separating Line thin

Confirmed National Speakers

 

IanFrazer2017_1.jpg

Professor Ian Frazer AC FRS - University of Queensland, Brisbane

Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers.  He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He is current president of the Australian Academy of Health and Medical Sciences, and a member of the Commonwealth Science Council. Most recently appointed chair of the federal governments Medical Research Future Fund.

 

Reigster Button v3